Update - December 2024 to May 2026. Topical fin/min
    5/8/2026

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Finasteride (topical) 0.3% nightly December 2024 to May 2026
    💧 Minoxidil (topical) 6% nightly December 2024 to May 2026
    the tone is 😀 positive with significant hair regrowth results.

    Other terms

    The user experienced significant hair regrowth using a nightly topical spray with 0.3% finasteride and 6% minoxidil, without side effects. Noticeable improvements were seen within three months, with continued progress over time.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Male androgenetic alopecia (Part II)

      9 citations , February 2005 in “The Journal of Men's Health & Gender”
      This article reviews treatment options for male androgenetic alopecia, including their distinct aims of arresting progression, stimulating regrowth, and concealing hair loss, and reports no new clinical results.

      research HAIR REGROWTH

      118 citations , April 1998 in “Dermatologic Clinics”
      This review discusses the advancements in understanding and treating androgenetic alopecia and alopecia areata but reports no clinical findings; the authors emphasize the need for further research on molecular control mechanisms.

      research Hair regrowth with novel hemp extract: A case series

      January 2023 in “International Journal of Trichology”
      In a case series, this study reported significant hair regrowth in both men and women with androgenetic alopecia using a topical hemp extract high in CBD, THCV, and CBDV over six months.

      research Management of Hair Loss

      74 citations , April 2005 in “Dermatologic Clinics”
      This article reviews treatment options for male-pattern and female-pattern hair loss, telogen effluvium, and alopecia areata, but provides no new clinical results; algorithmic management approaches are included.